Navigation Links
ERT Reports Third Quarter 2010 Results
Date:11/4/2010

, (2) higher costs associated with the ramp up of the RS operations to meet increased demand, (3) integration-related activities, and (4) a higher mix of site support revenue to total revenue as the RS site support revenue has a lower gross margin than services.  Non-GAAP gross margin percentage was 50.0% in the third quarter of 2010 compared to 57.2% for the second quarter of 2010 and 51.6% a year ago.  
  • GAAP operating income margin percentage was 14.6% in the third quarter of 2010 compared to 3.6% for the second quarter of 2010 and 20.7% a year ago.  The second quarter of 2010 was impacted by $3.8 million of acquisition and integration related costs due to the acquisition of RS.  Non-GAAP operating income margin percentage was 21.3% in the third quarter of 2010 compared to 19.7% for the second quarter of 2010 and 20.7% a year ago.  
  • GAAP net income was $3.2 million, or $0.06 per diluted share, in the third quarter of 2010 compared to $0.8 million, or $0.02 per diluted share, in the second quarter of 2010 and $2.8 million, or $0.06 per diluted share, a year ago.  Non-GAAP net income was $5.4 million, or $0.11 per diluted share, in the third quarter of 2010 compared to $4.0 million, or $0.08 per diluted share, in the second quarter of 2010 and $2.8 million, or $0.06 per diluted share, a year ago.  Unfavorable foreign exchange rate movements in the third quarter of 2010 resulted in a negative impact to GAAP and non-GAAP diluted net income per share of approximately $0.03 per diluted share.
  • Cash flow from operations was $6.4 million in the third quarter of 2010, compared to $7.1 million in the second quarter of 2010 and $5.6 million a year ago.
  • Cash and short-term investments totaled $19.4 million at September 30, 2010 compared to $78.8 million on December 31, 2009.  ERT had $21.0 million in debt as of September 30, 2010, down from $23.0 million at June 30, 2010 due
    '/>"/>

  • SOURCE eResearchTechnology, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute
    2. IRIDEX Reports Improved Third Quarter 2010 Financial Results
    3. Genoptix Reports Operating Results for the Third Quarter and First Nine Months of 2010
    4. Addus HomeCare Reports Third Quarter 2010 Results
    5. Isis Reports Financial Results and Highlights for Third Quarter 2010
    6. Amylin Pharmaceuticals Reports Third Quarter Financial Results
    7. Nektar Therapeutics Reports Third Quarter 2010 Financial Results
    8. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
    9. Cardiogenesis Reports Third Quarter 2010 Results
    10. Dendreon Reports Third Quarter 2010 Financial Results
    11. Volcano Reports 35 Percent Increase in Third Quarter Revenues; Records $9.6 Million Improvement in Year-Over-Year GAAP Profitability
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/1/2015)... -- Lee Tran & Liang LLP (LTL), ... and Yik Yak co-founder disputes, announced today ... most promising biotechnology start-ups in the country, Resilience Therapeutics, ... Sabados .  LTL represents Veronica Sara Weiner , ... fellow scientist at the Massachusetts Institute of Technology.      ...
    (Date:6/1/2015)... 2015   Regulus Therapeutics Inc . ( ... discovery and development of innovative medicines targeting microRNAs, ... Ph.D. has resigned as President and Chief Executive ... of Directors, effective today, to pursue investment opportunities ... previously served as Chief Medical Officer of Regulus, ...
    (Date:6/1/2015)... Pharmaceuticals, Inc. (Nasdaq: MACK ) today announced data for ... a Phase 1 investigator-sponsored study at the University of ... at the 2015 American Society of Clinical Oncology (ASCO) ... Results from this study show a tolerable safety profile ... intravenously.  Based in part on the data ...
    Breaking Medicine Technology:Lee Tran & Liang LLP Files Co-Founder Lawsuit against Leading Biotech Start-up Resilience 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 5
    ... DALLAS, Oct. 15 /PRNewswire-FirstCall/ -- ACCESS ... provided an update on its European commercial launch of ... debilitating side effect of radiation treatment and chemotherapy. ... five European countries, having been granted the CE mak ...
    ... Pharmaceuticals, Inc. announced today that new data confirm that ... of fat absorption in children aged 7-11 years who ... (CF). EPI is a condition resulting from a deficiency ... are necessary to digest nutrients in food. CREON® has ...
    Cached Medicine Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 4CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 2CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 3CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 4CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 5CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 6
    (Date:6/1/2015)... 02, 2015 The National Association ... as a 2015-2016 inductee into its VIP Professional ... this prestigious distinction for leadership in safety, environment, health ... organization exclusively for professional women, boasting more than 700,000 ... pleased to present Lourinda with this important honor,” said ...
    (Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Lenita F. Cornett, DSL, LSSBB (C), First Sergeant A ... VIP Woman of the Year Circle. She is recognized ... NAPW is the nation's leading networking organization exclusively for ... 200 operating Local Chapters. , “I'm pleased to recognize ...
    (Date:6/1/2015)... York, New York (PRWEB) June 01, 2015 ... ( http://www.testosteronelawsuithub.com/ ) has amended the Case Management ... Inc.’s AndroGel testosterone gel. The Amended Order which ... of Illinois on May 29, 2015, directs the parties ... Court by August 10, 2015 that outlines parameters and ...
    (Date:6/1/2015)... D.C. (PRWEB) June 01, 2015 Linda Kincaid, ... and had an irregular heartbeat. At first she thought it ... found out it was much more than that. After going ... disease. Linda admitted she felt afraid about what might happen ... five million Americans are diagnosed with valve disease each year. ...
    (Date:6/1/2015)... 2015 EBSCO Health , a ... DynaMed Plus™ , a cross-platform evidence-based clinical decision ... provides clinicians with the ideal blend of evidence and ... , DynaMed Plus is a significant enhancement over ... most frequently updated evidence-based content. DynaMed Plus content is ...
    Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Lourinda Willey, Owner and Principal of Lourinda R. Willey LLC, Into its VIP Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Lenita F. Cornett, First Sergeant of the US Military, Into its VIP Professional Woman of the Year Circle 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 4Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 4
    ... fruit flies get high cholesterol and become obese? The same ... too rich in fats. More importantly, according to two ... fruit flies use the same molecular mechanisms as humans to ... of stored fat that contributes to obesity. The findings mean ...
    ... , ARLINGTON, Va., Dec. 2 ... life that give us meaning, joy and peace, the LIFE ... using the popular photo-sharing Web site flickr.com. The winning photos ... Foundation,s Web site at www.lifehappens.org/wondersphotos . , Contestants ...
    ... Dec. 2 Aegis Health Group, the nation,s leading ... chief development officer. As a member of Aegis, executive ... the sales and marketing staff as they focus on ... and physician relationships. , To this newly created position, ...
    ... point to death from TB, not Addison,s, researcher says ... Pride and Prejudice and Emma ... has long been believed, says one British scholar. , Since ... many historians and other experts have believed the cause was ...
    ... , LONDON, Dec. 2 ... therapies to treat lifestyle disorders. In the near future, the ... therapies and novel drugs to treat such conditions and reduce ... New analysis from Frost & Sullivan ( http://www.pharma.frost.com ), ...
    ... ... Links Medical Products Inc., an industry leader in healthcare products for hospitals ... Irvine Spectrum. The new facility is located at 9247 Research Drive, Irvine, ... Spectrum plus an assembly and distribution operation in Indio, California. This most ...
    Cached Medicine News:Health News:Latest epidemic? High cholesterol, obesity in fruit flies 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 3Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:Aegis Health Group Hires Pearson Talbert as Chief Development Officer 2Health News:New Light on Jane Austen's Final Chapter 2Health News:Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is Key to the Expansion of the European Lifestyle Disorders Therapeutics Market, Says Frost & Sullivan 2Health News:Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is Key to the Expansion of the European Lifestyle Disorders Therapeutics Market, Says Frost & Sullivan 3Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 2Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 3
    Ruschelit® PVC. Magill tip-nasoral. Black positioning ring. High volume/low pressure cuff. X-ray opaque line. Graduated. Single use....
    Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff.Connector is permanently fixed into the tube. X-ray opaque. Graduated. Single use. Sterile...
    Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Gradua...
    Laser resistant tubes for use with CO2 and KTP Lasers., ,Designed for airway management during laser surgery of the larynx or other areas in close proximity to the trachea....
    Medicine Products: